Allogene Therapeutics Announces Publication of Durable Response Data from Phase 1 ALPHA/ALPHA2 Trials of the Allogeneic CAR T Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma in the Journal of Clinical Oncology
SOUTH SAN FRANCISCO, Calif., Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Allogene Therapeutics, Inc. ( Nasdaq: ALLO ) , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T ( AlloCAR T™ ) products for cancer and autoimmune disease, today announced the publication of data ...
Cenovus to hold fourth-quarter and full-year conference call and webcast on February 20
CALGARY, Alberta, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Cenovus Energy Inc. ( TSX:CVE ) ( NYSE:CVE ) will release its fourth-quarter and full-year 2024 results on Thursday, February 20, 2025. The news release will provide consolidated fourth-quarter operating and financial information.
Opinion | As Trump's trade war gathers steam, China and Europe must cooperate
By fostering innovation and open markets - particularly in the automotive sector - China and the EU can show how major powers can work together despite differences.
Steve Jobs Feared His Porsche 911 Would Display His Wealth And Cost Him A $20 Million Deal-So He Scrambled To Hide It From Ross Perot - Apple ( NASDAQ:AAPL )
Steve Jobs was known for his obsession with perfection in the products he created and the cars he drove. His love for the Porsche 911 was legendary, and for years, he swapped his black Porsche for a new one every six months for a very Jobs-like reason - to avoid having a license plate.
Cenovus to hold fourth-quarter and full-year conference call and webcast on February 20 - Cenovus Energy ( NYSE:CVE )
CALGARY, Alberta, Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Cenovus Energy Inc. CVE CVE will release its fourth-quarter and full-year 2024 results on Thursday, February 20, 2025. The news release will provide consolidated fourth-quarter operating and financial information.
Orrstown Financial Services, Inc. Announces Promotion of Adam Metz to Senior Executive Vice President and Chief Operating Officer - Orrstown Finl Servs ( NASDAQ:ORRF )
HARRISBURG, Pa., Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Orrstown Financial Services, Inc. ORRF ( the "Company" ) today announced that Adam L.
Tevogen Bio CEO Congratulates RFK Jr. on His Confirmation as Secretary of the HHS; Echoes Commitment to Innovation and Affordability for Americans
WARREN, N.J., Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Ryan Saadi, MD, MPH, Founder and CEO of Tevogen Bio ( "Tevogen Bio Holdings Inc." or "Company" ) ( Nasdaq: TVGN ) , a clinical-stage specialty immunotherapy biotech company, congratulates Robert F.
NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock
MOUNTAIN VIEW, Calif., Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- NeuroPace, Inc. ( Nasdaq: NPCE ) today announced that it intends to offer and sell, in an underwritten public offering, $65 million of shares of its common stock. All of the shares are being offered by NeuroPace.
Coinbase Revenue Surges to $2.3 Billion as Bitcoin Booms and Retail Returns
Crypto exchange Coinbase had a huge Q4 thanks to the election of Donald Trump and Bitcoin's subsequent surge.
Outset Medical Announces Resolution of Warning Letter
SAN JOSE, Calif., Feb. 13, 2025 ( GLOBE NEWSWIRE ) -- Outset Medical, Inc. ( Nasdaq: OM ) ( "Outset" ) , a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced it has been notified by the Food and Drug Administration ...
